Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024
Cytek Biosciences (Nasdaq: CTKB), a leading cell analysis solutions company, has announced it will report its second quarter 2024 financial results after market close on Tuesday, August 6, 2024. The company's management will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day to discuss the results, business developments, and outlook. Investors can access the live audio webcast on the company's website at investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB), un'azienda leader nelle soluzioni di analisi cellulare, ha annunciato che riporterà i suoi risultati finanziari del secondo trimestre 2024 dopo la chiusura del mercato il martedì 6 agosto 2024. La dirigenza dell'azienda condurrà una chiamata in conferenza e una webcasting alle 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time dello stesso giorno per discutere i risultati, gli sviluppi aziendali e le prospettive future. Gli investitori possono accedere al webcast audio live sul sito web dell'azienda all'indirizzo investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB), una empresa líder en soluciones de análisis celular, ha anunciado que informará sobre sus resultados financieros del segundo trimestre de 2024 después del cierre del mercado el martes 6 de agosto de 2024. La dirección de la empresa llevará a cabo una conferencia telefónica y una transmisión web a las 1:30 p.m. Hora del Pacífico / 4:30 p.m. Hora del Este del mismo día para discutir los resultados, los desarrollos empresariales y las perspectivas. Los inversores pueden acceder a la transmisión de audio en vivo en el sitio web de la empresa en investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB)는 셀 분석 솔루션의 선두 기업으로서 2024년 2분기 재무 결과를 2024년 8월 6일 화요일에 장 마감 후 발표할 예정이라고 밝혔습니다. 회사 경영진은 같은 날 태평양 표준시 기준 오후 1시 30분 / 동부 표준시 기준 오후 4시 30분에 결과, 비즈니스 개발 및 전망에 대해 논의하는 컨퍼런스 콜과 웹캐스트를 개최합니다. 투자자들은 회사 웹사이트인 investors.cytekbio.com에서 라이브 오디오 웹캐스트에 접속할 수 있습니다.
Cytek Biosciences (Nasdaq: CTKB), une entreprise leader dans les solutions d'analyse cellulaire, a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2024 après la fermeture du marché le mardi 6 août 2024. La direction de l'entreprise animera une conférence téléphonique et un webinaire le même jour à 13h30 heure du Pacifique / 16h30 heure de l'Est pour discuter des résultats, des développements commerciaux et des perspectives. Les investisseurs peuvent accéder à la diffusion audio en direct sur le site web de l'entreprise à l'adresse investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB), ein führendes Unternehmen für Zellanalyselösungen, hat angekündigt, dass es seine finanziellen Ergebnisse für das zweite Quartal 2024 nach Börsenschluss am Dienstag, den 6. August 2024 bekannt geben wird. Das Management des Unternehmens wird am selben Tag um 13:30 Uhr Pazifischer Zeit / 16:30 Uhr Östlicher Zeit eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse, Geschäftsentwicklungen und Ausblicke zu erörtern. Anleger können die Live-Audio-Webcast auf der Unternehmenswebsite unter investors.cytekbio.com abrufen.
- None.
- None.
FREMONT, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the second quarter 2024 after market close on Tuesday, August 6, 2024. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.
Live audio of the webcast will be available on the “Investors” section of the company website at investors.cytekbio.com.
About Cytek Biosciences, Inc.
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s platform includes its core instruments, the Cytek Aurora™ and Northern Lights™ systems; its cell sorter, the Cytek Aurora CS; the flow cytometer and imaging products under the Amnis® and Guava® brands; the Cytek Orion™ reagent cocktail preparation system, and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.
Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use in China and the European Union).
Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, Cytek Orion, Amnis and Guava are trademarks of Cytek Biosciences, Inc.
In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X (formerly Twitter) account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts.
Media Contact:
Stephanie Olsen
Lages & Associates
(949) 453-8080
stephanie@lages.com
Investor Contact:
Paul Goodson
Head of Investor Relations
Cytek Biosciences
pgoodson@cytekbio.com
FAQ
When will Cytek Biosciences (CTKB) report its Q2 2024 financial results?
What time is Cytek Biosciences' (CTKB) Q2 2024 earnings call?
Where can I access Cytek Biosciences' (CTKB) Q2 2024 earnings webcast?
What will be discussed in Cytek Biosciences' (CTKB) Q2 2024 earnings call?
